News

Osborne Clarke advises Lucid Group on HealthCare21 acquisition


Written on 13 September 2019

International legal practice Osborne Clarke has advised Lucid Group on its acquisition of healthcare consultancy HealthCare21.

Lucid Group, backed by LDC, is an industry leader in providing medical communications that transforms patients’ lives. Lucid Group currently comprises five medical communications specialists, Bluedog, Leading Edge, Lighthouse, Lucid Partners and ViVid. HealthCare21 has been producing remarkable healthcare materials and programmes for its clients, reaching and engaging healthcare audiences for over 23 years. The team has exceptional skills in scientific strategy, content creation, editorial excellence and digital design – capabilities that Lucid Group needs every day as it crafts impactful client campaigns.

Dennis O’Brien, Chief Executive at Lucid Group commented: “We’re fantastically excited to welcome our new colleagues from HealthCare21 into the Lucid Group. We had great support from Osborne Clarke in helping deliver the acquisition – their technical expertise and counsel was valuable throughout, as always.”

The Osborne Clarke team was led by Partner Alistair Francis and included Senior Associate Sarah Crabtree (corporate), Partner Mathew Oliver and Associate Helena Zaba (tax) and Associate Director Olivia Sinfield (employment).

Osborne Clarke previously advised Lucid Group on its acquisition of Bluedog.

Osborne Clarke has a market leading reputation as legal advisers to innovative businesses in the marketing, communications, design, content and technology sectors, particularly with transformative transactional projects. It is one of the leading law firms in the UK and internationally, working with both global businesses and also fast-growth start-ups and market challengers. The team advises at every stage of company development across all corporate issues, from equity and debt fundraisings to M&A, IPOs and JVs.